Annual Operating Profit
-$203.20 M
+$53.68 M+20.90%
December 31, 2023
Summary
- As of March 2, 2025, CHRS annual operating income is -$203.20 million, with the most recent change of +$53.68 million (+20.90%) on December 31, 2023.
- During the last 3 years, CHRS annual operating profit has fallen by -$359.52 million (-229.99%).
- CHRS annual operating profit is now -229.99% below its all-time high of $156.32 million, reached on December 31, 2020.
Performance
CHRS Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$6.39 M
+$14.12 M+68.86%
September 30, 2024
Summary
- As of March 2, 2025, CHRS quarterly operating income is -$6.39 million, with the most recent change of +$14.12 million (+68.86%) on September 30, 2024.
- Over the past year, CHRS quarterly operating profit has increased by +$25.62 million (+80.04%).
- CHRS quarterly operating profit is now -107.55% below its all-time high of $84.62 million, reached on September 30, 2016.
Performance
CHRS Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$138.33 M
+$25.62 M+15.63%
September 30, 2024
Summary
- As of March 2, 2025, CHRS TTM operating income is -$138.33 million, with the most recent change of +$25.62 million (+15.63%) on September 30, 2024.
- Over the past year, CHRS TTM operating profit has increased by +$47.46 million (+25.55%).
- CHRS TTM operating profit is now -168.12% below its all-time high of $203.05 million, reached on June 30, 2020.
Performance
CHRS TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
CHRS Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +20.9% | +80.0% | +25.6% |
| 3 y3 years | -230.0% | +81.5% | +40.9% |
| 5 y5 years | +0.6% | +81.5% | +40.9% |
CHRS Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +23.0% | at high | +92.1% | at high | +47.6% |
| 5 y | 5-year | -230.0% | +23.0% | -109.8% | +96.2% | -168.1% | +47.6% |
| alltime | all time | -230.0% | +23.0% | -107.5% | +96.2% | -168.1% | +47.6% |
Coherus BioSciences Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$6.39 M(-68.9%) | -$138.33 M(-15.6%) |
| Jun 2024 | - | -$20.51 M(-51.8%) | -$163.94 M(-7.9%) |
| Mar 2024 | - | -$42.52 M(-38.3%) | -$177.98 M(-12.4%) |
| Dec 2023 | -$203.20 M(-20.9%) | -$68.91 M(+115.3%) | -$203.20 M(+9.4%) |
| Sep 2023 | - | -$32.01 M(-7.3%) | -$185.79 M(-20.7%) |
| Jun 2023 | - | -$34.54 M(-49.0%) | -$234.23 M(-3.9%) |
| Mar 2023 | - | -$67.75 M(+31.6%) | -$243.70 M(-5.1%) |
| Dec 2022 | -$256.88 M(-2.6%) | -$51.49 M(-36.0%) | -$256.88 M(+4.9%) |
| Sep 2022 | - | -$80.45 M(+82.8%) | -$244.93 M(+24.2%) |
| Jun 2022 | - | -$44.01 M(-45.6%) | -$197.27 M(+11.2%) |
| Mar 2022 | - | -$80.92 M(+104.6%) | -$177.42 M(-32.8%) |
| Dec 2021 | -$263.86 M(-268.8%) | -$39.55 M(+20.6%) | -$263.86 M(+26.9%) |
| Sep 2021 | - | -$32.79 M(+35.7%) | -$207.89 M(+47.0%) |
| Jun 2021 | - | -$24.16 M(-85.6%) | -$141.38 M(+172.4%) |
| Mar 2021 | - | -$167.36 M(-1118.9%) | -$51.91 M(-133.2%) |
| Dec 2020 | $156.32 M(+45.1%) | $16.43 M(-51.3%) | $156.32 M(-15.5%) |
| Sep 2020 | - | $33.72 M(-48.4%) | $184.93 M(-8.9%) |
| Jun 2020 | - | $65.31 M(+59.8%) | $203.05 M(+22.9%) |
| Mar 2020 | - | $40.87 M(-9.2%) | $165.24 M(+53.3%) |
| Dec 2019 | $107.77 M(-152.7%) | $45.03 M(-13.1%) | $107.77 M(+4726.2%) |
| Sep 2019 | - | $51.84 M(+88.6%) | $2.23 M(-102.1%) |
| Jun 2019 | - | $27.49 M(-265.6%) | -$106.58 M(-40.5%) |
| Mar 2019 | - | -$16.60 M(-72.6%) | -$178.98 M(-12.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$204.42 M(-11.9%) | -$60.50 M(+6.2%) | -$204.42 M(+7.4%) |
| Sep 2018 | - | -$56.97 M(+26.9%) | -$190.38 M(+0.2%) |
| Jun 2018 | - | -$44.91 M(+6.8%) | -$190.02 M(-5.8%) |
| Mar 2018 | - | -$42.03 M(-9.5%) | -$201.75 M(-13.1%) |
| Dec 2017 | -$232.14 M(+100.2%) | -$46.47 M(-17.9%) | -$232.14 M(-10.4%) |
| Sep 2017 | - | -$56.62 M(-0.0%) | -$259.13 M(+119.8%) |
| Jun 2017 | - | -$56.64 M(-21.8%) | -$117.90 M(-4.9%) |
| Mar 2017 | - | -$72.42 M(-1.4%) | -$124.00 M(+7.0%) |
| Dec 2016 | -$115.93 M(-47.1%) | -$73.46 M(-186.8%) | -$115.93 M(+22.4%) |
| Sep 2016 | - | $84.62 M(-234.9%) | -$94.68 M(-62.2%) |
| Jun 2016 | - | -$62.74 M(-2.5%) | -$250.51 M(+1.6%) |
| Mar 2016 | - | -$64.35 M(+23.3%) | -$246.67 M(+12.6%) |
| Dec 2015 | -$219.07 M(+238.7%) | -$52.21 M(-26.7%) | -$219.07 M(+13.3%) |
| Sep 2015 | - | -$71.22 M(+20.9%) | -$193.42 M(+50.4%) |
| Jun 2015 | - | -$58.90 M(+60.3%) | -$128.63 M(+46.7%) |
| Mar 2015 | - | -$36.75 M(+38.4%) | -$87.67 M(+35.5%) |
| Dec 2014 | -$64.68 M(+79.7%) | -$26.56 M(+313.5%) | -$64.68 M(+33.1%) |
| Sep 2014 | - | -$6.42 M(-64.2%) | -$48.61 M(-0.7%) |
| Jun 2014 | - | -$17.94 M(+30.4%) | -$48.97 M(+57.8%) |
| Mar 2014 | - | -$13.76 M(+31.2%) | -$31.03 M(+79.7%) |
| Dec 2013 | -$35.99 M(-6.6%) | -$10.49 M(+54.6%) | -$17.27 M(+154.6%) |
| Sep 2013 | - | -$6.78 M | -$6.78 M |
| Dec 2012 | -$38.52 M | - | - |
FAQ
- What is Coherus BioSciences annual operating income?
- What is the all time high annual operating profit for Coherus BioSciences?
- What is Coherus BioSciences annual operating profit year-on-year change?
- What is Coherus BioSciences quarterly operating income?
- What is the all time high quarterly operating profit for Coherus BioSciences?
- What is Coherus BioSciences quarterly operating profit year-on-year change?
- What is Coherus BioSciences TTM operating income?
- What is the all time high TTM operating profit for Coherus BioSciences?
- What is Coherus BioSciences TTM operating profit year-on-year change?
What is Coherus BioSciences annual operating income?
The current annual operating profit of CHRS is -$203.20 M
What is the all time high annual operating profit for Coherus BioSciences?
Coherus BioSciences all-time high annual operating income is $156.32 M
What is Coherus BioSciences annual operating profit year-on-year change?
Over the past year, CHRS annual operating income has changed by +$53.68 M (+20.90%)
What is Coherus BioSciences quarterly operating income?
The current quarterly operating profit of CHRS is -$6.39 M
What is the all time high quarterly operating profit for Coherus BioSciences?
Coherus BioSciences all-time high quarterly operating income is $84.62 M
What is Coherus BioSciences quarterly operating profit year-on-year change?
Over the past year, CHRS quarterly operating income has changed by +$25.62 M (+80.04%)
What is Coherus BioSciences TTM operating income?
The current TTM operating profit of CHRS is -$138.33 M
What is the all time high TTM operating profit for Coherus BioSciences?
Coherus BioSciences all-time high TTM operating income is $203.05 M
What is Coherus BioSciences TTM operating profit year-on-year change?
Over the past year, CHRS TTM operating income has changed by +$47.46 M (+25.55%)